Market closedNon-fractional
FRACTYL HEALTH/GUTS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About FRACTYL HEALTH
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
Ticker
GUTS
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Burlington, United States
Employees
111
Website
fractyl.com
FRACTYL HEALTH Metrics
BasicAdvanced
$194M
Market cap
-
P/E ratio
-$1.82
EPS
-
Beta
-
Dividend rate
Price and volume
Market cap
$194M
Financial strength
Current ratio
9.379
Quick ratio
9.151
Long term debt to equity
34.088
Total debt to equity
34.088
Management effectiveness
Return on equity (TTM)
-114.91%
Valuation
Price to revenue (TTM)
1,307.867
Price to book
2.29
Price to tangible book (TTM)
2.29
Growth
Revenue change (TTM)
2,860.00%
3-year earnings per share growth (CAGR)
-57.01%
What the Analysts think about FRACTYL HEALTH
Analyst Ratings
Majority rating from 2 analysts.
FRACTYL HEALTH Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$3.3M
-82.72%
Profit margin
0.00%
NaN%
FRACTYL HEALTH Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q1 24
Q2 24
Actual
-$0.17
-
Expected
-$0.30
-$0.46
Surprise
-43.33%
-
FRACTYL HEALTH News
AllArticlesVideos
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
GlobeNewsWire·1 month ago
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
GlobeNewsWire·1 month ago
Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President's Select Oral Presentation at the American Diabetes Association's 84th Scientific Sessions
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for FRACTYL HEALTH stock?
FRACTYL HEALTH (GUTS) has a market cap of $194M as of July 27, 2024.
What is the P/E ratio for FRACTYL HEALTH stock?
The price to earnings (P/E) ratio for FRACTYL HEALTH (GUTS) stock is 0 as of July 27, 2024.
Does FRACTYL HEALTH stock pay dividends?
No, FRACTYL HEALTH (GUTS) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next FRACTYL HEALTH dividend payment date?
FRACTYL HEALTH (GUTS) stock does not pay dividends to its shareholders.
What is the beta indicator for FRACTYL HEALTH?
FRACTYL HEALTH (GUTS) does not currently have a Beta indicator.
Buy or sell FRACTYL HEALTH stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.